Cell-free DNA as a novel marker in cancer therapy

被引：0
|
作者：
Kato, Shumei [1 ]
Janku, Filip [1 ]
机构：
[1] Univ Texas MD Anderson Canc Ctr, Dept Invest Canc Therapeut, Houston, TX 77030 USA
来源：
BIOMARKERS IN MEDICINE | 2015年 / 9卷 / 07期
基金：
美国国家卫生研究院;
关键词：
cancer; cell-free DNA; liquid biopsy; personalized medicine; CIRCULATING TUMOR DNA; TYROSINE KINASE INHIBITORS; METASTATIC BREAST-CANCER; ERDHEIM-CHESTER DISEASE; BRAF MUTATIONS; ACQUIRED-RESISTANCE; INTRATUMOR HETEROGENEITY; COLORECTAL-CANCER; PLASMA; KRAS;
D O I：
10.2217/BMM.15.38
中图分类号：
R-3 [医学研究方法]; R3 [基础医学];
学科分类号：
1001 ;
摘要：
Advances in next-generation sequencing have provided new insights and new therapeutic options for patients with cancer. However, assessment of genomic aberrations, which is required for precision medicine, has been challenging because of the difficulties in capturing intratumoral heterogeneity and in real-time assessment of tumors. Recent advances in technology have enabled detection and analysis of cell-free DNA in cancer patients, which provides real-time assessment of tumor evolution. Here, we review the recent advances in our understanding of the clinical utility of cell-free DNA and the future directions for its use in cancer management.
引用
收藏
页码：703 / 712
页数：10
相关论文
共 50 条
  • [21] Circulating cell-free DNA for non-invasive cancer management
    Stewart, Caitlin M.
    Tsui, Dana W. Y.
    CANCER GENETICS, 2018, 228 : 169 - 179
  • [22] Cell-Free DNA Fragmentation Patterns in a Cancer Cell Line
    Ungerer, Vida
    Bronkhorst, Abel J.
    Uhlig, Carsten
    Holdenrieder, Stefan
    DIAGNOSTICS, 2022, 12 (08)
  • [23] Multi-marker analysis of circulating cell-free DNA toward personalized medicine for colorectal cancer
    Mouliere, Florent
    El Messaoudi, Safia
    Pang, Dalong
    Dritschilo, Anatoly
    Thierry, Alain R.
    MOLECULAR ONCOLOGY, 2014, 8 (05) : 927 - 941
  • [24] Cell-Free DNA: Hope and Potential Application in Cancer
    Yan, Yan-yan
    Guo, Qiao-ru
    Wang, Feng-hua
    Adhikari, Rameshwar
    Zhu, Zhuang-yan
    Zhang, Hai-yan
    Zhou, Wen-min
    Yu, Hua
    Li, Jing-quan
    Zhang, Jian-ye
    FRONTIERS IN CELL AND DEVELOPMENTAL BIOLOGY, 2021, 9
  • [25] The Detection of Cancer Epigenetic Traces in Cell-Free DNA
    Koval, Anastasia P.
    Blagodatskikh, Konstantin A.
    Kushlinskii, Nikolay E.
    Shcherbo, Dmitry S.
    FRONTIERS IN ONCOLOGY, 2021, 11
  • [26] Using circulating cell-free DNA to monitor personalized cancer therapy
    Oellerich, Michael
    Schuetz, Ekkehard
    Beck, Julia
    Kanzow, Philipp
    Plowman, Piers N.
    Weiss, Glen J.
    Walson, Philip D.
    CRITICAL REVIEWS IN CLINICAL LABORATORY SCIENCES, 2017, 54 (03) : 205 - 218
  • [27] Cell-free DNA diagnostics: current and emerging applications in oncology
    Muluhngwi, Penn
    Valdes, Roland, Jr.
    Fernandez-Botran, Rafael
    Burton, Eric
    Williams, Brian
    Linder, Mark W.
    PHARMACOGENOMICS, 2019, 20 (05) : 367 - 380
  • [28] Seminal Cell-Free DNA Assessment as a Novel Prostate Cancer Biomarker
    Ponti, Giovanni
    Maccaferri, Monia
    Mandrioli, Mauro
    Manfredini, Marco
    Micali, Salvatore
    Cotugno, Michele
    Bianchi, Giampaolo
    Ozben, Tomris
    Pellacani, Giovanni
    Del Prete, Chiara
    Tomasi, Aldo
    PATHOLOGY & ONCOLOGY RESEARCH, 2018, 24 (04) : 941 - 945
  • [29] Diagnostic and Therapeutic Potential of Circulating-Free DNA and Cell-Free RNA in Cancer Management
    Hassan, Sadia
    Shehzad, Adeeb
    Khan, Shahid Ali
    Miran, Waheed
    Khan, Salman
    Lee, Young-Sup
    BIOMEDICINES, 2022, 10 (08)
  • [30] Increased Plasma Circulating Cell-Free DNA Could Be a Potential Marker for Oral Cancer
    Lin, Li-Han
    Chang, Kuo-Wei
    Kao, Shou-Yen
    Cheng, Hui-Wen
    Liu, Chung-Ji
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2018, 19 (11)
12345